A growing body of research points to the role of the gut-brain axis in the development of Parkinson disease, with inflammatory bowel disease, leaky gut, and altered gut microbiota observed in the gut, often years before the onset of symptoms of Parkinson disease.
In this review, the author discusses the use of autoantibodies as biomarkers for the differential diagnosis of neuropsychiatric systemic lupus erythematosus.
Study researchers examined whether baseline MRI-markers and demographic and clinical data can help predict cognitive worsening patients with multiple sclerosis.
